CryoPort Completes Move to New Facility

LAKE FOREST, CA -- (MARKET WIRE) -- 09/20/07 -- CryoPort, Inc. (OTCBB: CYRX) announced today that it has successfully completed the move of its corporate offices, manufacturing and recycling operations to a new, larger facility with approximately 50 percent more warehouse and office space. The Company's new contact information is as follows:

CryoPort, Inc.
20382 Barents Sea Circle
Lake Forest, CA  92630
Phone: 949-470-2300
Fax:   949-470-2306

CryoPort's CEO Peter Berry commented, "The increased capacity of the new facility will allow us to meet anticipated demand for the launch of the CryoPort Express® One-Way Shipper System as we ramp up manufacturing and implement the platform for global recycling. In anticipation of this move, we have already placed orders several weeks ago for the necessary raw materials and required new production equipment."

About CryoPort, Inc.

Cryoport (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Investor Relations:
CryoPort, Inc.
949-470-2300